Table 2.
Study characteristics
| Author | Study Design | No. | HIV+ | HIV+/ART− | HIV+/ART+ | HIV− | Follow-up period (months) | Site measured | Variables Adjusted |
|---|---|---|---|---|---|---|---|---|---|
| Hsue et al.2004[1] | PCO | 211 | 148 | 0 | 148 | 63 | 12 | Mean of 12 sites | Age and Sex |
| Hsue et al.2012 [39] | PCO | 347 | 300 | 300 | 0 | 47 | 28 | CCA,ICA,BCC | Demographics, Traditional risk factors, hsCRP, IMT progression |
| Kelesidis et al.2012 [38] | PCO | 91 | 55 | 26 | 29 | 36 | 144 | RCC | Age, sex, race/ethnicity, smoking, BP and menopause |
| Hileman et al.2013 [40] | PCO | 130 | 85 | 85 | 0 | 45 | 48 | CCA,BCC | CVD risk factors, Age, sex and BMI |
| Hileman et al.2014 [41] | PCO | 83 | 42 | 42 | 41 | 96 | CCA, BCC | CVD risk factors, Age, sex and BMI | |
| Papita et al.2011 [51] | CS | 99 | 63 | 7 | 56 | 36 | RCC,CBA | Age and Sex | |
| Lorenz et al.2008[3] | CS | 1460 | 292 | 0 | 292 | 1168 | CCA/BIF | Age, sex, BMI, DM, BP, Cholesterol, use of statins and smoking | |
| Seminari et al.2002 [54] | CS | 59 | 43 | 15 | 28 | 16 | MCCA/CCCA | Age, Weight, Height, BP and HIV risk factors | |
| van Vonderen et al.2006[42] | CS | 129 | 77 | 22 | 55 | 52 | RCC/CFA/CBA | Age, BMI, Mean arterial BP, Smoking and Createnine clearance | |
| Oliviero et al.2009 [52] | CS | 79 | 38 | 38 | 0 | 41 | Mean of 12 sites | Age, sex, BMI and smoking | |
| Mondy et al.2008 [53] | CS | 100 | 50 | 0 | 50 | 50 | BCC | Age, Sex, race and BMI | |
| Jung et al.2015 [45] | CS | 1792 | 1282 | 0 | 0 | 510 | BCC | Age, race/ethnicity, Serum lipids, BP and Smoking | |
| Cristofaro et al.2011 [47] | CS | 421 | 286 | 64 | 222 | 135 | CCA | Unadjusted | |
| Desvarieux et al.2013 [43] | CS | 150 | 100 | 50 | 50 | 50 | Mean of 12 sites | Age,smoking,DM,HT | |
| Fitch at el.2013 [48] | CS | 318 | 166 | 0 | 0 | 152 | RCC& ICC | Age, race, gender, traditional CVD risks, use of statins, Ant-HT, ART use CD4 and VL | |
| Karim et al.2013 [46] | CS | 584 | 170 | 0 | 0 | 414 | RCC | Age, race, BMI, DM, Smoking, alcohol intake, IDU, non-IDU, ART, HIV and VL | |
| Monroe et al.2012 [44] | CS | 856 | 534 | 0 | 0 | 322 | RCC/ICA/CBA | Unadjusted | |
| Vigano et al.2010[11] | CS | 42 | 23 | 0 | 0 | 19 | CCA | Age, gender and BMI | |
| Zormpala et al.2012 [49] | CS | 229 | 105 | 0 | 0 | 124 | R&L CCA | Age, sex and Conversional CVD frisk factors | |
| Kristoffersen et al.2013 [50] | CS | 210 | 105 | 0 | 105 | 105 | Did not specify | Age, gender and Smoking |
*
PCO – Prospective cohort study; CS- Cross-sectional; BCC – Bifurcation common carotid; CFA – Common femoral artery; CBA – Common brachial artery; LCC – Left common carotid; ICA – Internal carotid artery; RCC – Right common carotid; hsCRP-high sensitive C-reactive protein; IMT-Intima Media Thickness; BP-Blood Pressure; CVD- Cardiovascular Disease; BMI-Body Mass Index; DM-Diabetes Mellitus; HT- Hypertension; ART-Antiretroviral Therapy; IDU- Intravenous Drug Users; VL- Viral Load